Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04341441Phase 3Terminated
Will Hydroxychloroquine Impede or Prevent COVID-19
CoronavirusCoronavirus InfectionsCOVID-19+1 more
PrincipalinvestigatorStart date: 2020-04-07
NCT03677180Completed
National Cardiogenic Shock Initiative
Acute Myocardial InfarctionCardiogenic ShockHeart Attack+2 more
PrincipalinvestigatorStart date: 2016-05-19

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Babar Basir, DO

Henry Ford Health System

Similar
1 trials

Shared therapeutic areas:

Acute Myocardial InfarctionShock, CardiogenicMyocardial Infarction+2 more

Worked with same sponsors:

Abiomed Inc.Chiesi Farmaceutici S.p.A.+1 more
Collaborated on 1 trial
Similarity Score54%

Dee Dee Wang, MD

Henry Ford Health System

Moderately Similar
1 trials

Shared therapeutic areas:

CoronavirusCoronavirus InfectionsCOVID-19+1 more

Worked with same sponsors:

Henry Ford Health System
Collaborated on 1 trial
Similarity Score44%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19Coronavirus InfectionsCoronavirus+1 more
Similarity Score13%

Lorenzo Berra, MD

Massachusetts General Hospital

Related
16 trials

Shared therapeutic areas:

Coronavirus InfectionsCoronavirus
Similarity Score7%

Ron Waksman, MD

Medstar Health Research Institute

Related
18 trials

Shared therapeutic areas:

Acute Myocardial InfarctionMyocardial Infarction
Similarity Score7%

Andrea Natale, MD

Texas Cardiac Arrhythmia Research Foundation

Related
18 trials

Shared therapeutic areas:

COVID-19Myocardial Infarction
Similarity Score7%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score3%

Michael S Avidan, MBBcH

Washington University School of Medicine

Related
10 trials

Shared therapeutic areas:

Myocardial Infarction
Similarity Score3%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

COVID-19
Similarity Score3%

Amir Lerman, MD

Mayo Clinic

Related
15 trials

Shared therapeutic areas:

Myocardial Infarction
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04341441Phase 3PrincipalInvestigator

Will Hydroxychloroquine Impede or Prevent COVID-19

CoronavirusCoronavirus InfectionsCOVID-19+1 more
Terminated
NCT03677180PrincipalInvestigator

National Cardiogenic Shock Initiative

Acute Myocardial InfarctionCardiogenic ShockHeart Attack+2 more
Completed

All 2 trials loaded